Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

16-Slice CT Not Advisable For Routine Coronary Diagnosis, Study Says

This article was originally published in The Gray Sheet

Executive Summary

Noninvasive 16-slice computed tomography (CT) for evaluating coronary disease is not recommended as a routine alternative to catheter-based diagnostic imaging by one of the first multi-site studies conducted in this field

You may also be interested in...



Medicare Panel Calls For Outcomes Data On Non-Invasive Coronary Imaging

More evidence is needed to support the value of non-invasive imaging techniques such as computer tomographic angiography (CTA) in making a diagnosis or prognosis for coronary artery disease, CMS' Medicare Coverage Advisory Committee concluded during a May 18 meeting

Could Revisiting US Approval Decisions Become Less Rare?

While not identifying specific situations raising potential questions, the FDA commissioner uses his appearance at agency's annual rare disease event to advise regulatory decisions may be revisited as more data becomes available. 

NGM’s Pan-FGF Receptor Approach In NASH Shows Benefits And Drawbacks

NGM’s Phase II data for FGF19 analog aldafermin shows ability to reduce liver fat and improve fibrosis, but also raises LDL-C. Company says it gets a broader effect this way and can manage the increased cholesterol.

UsernamePublicRestriction

Register

MT023810

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel